Peter MacCallum Cancer Centre, Australia
114
26
45
34
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.9%
9 terminated/withdrawn out of 114 trials
79.1%
-7.5% vs industry average
8%
9 trials in Phase 3/4
12%
4 of 34 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (114)
Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma
Role: lead
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
Role: lead
EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
Role: lead
Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
Role: lead
Novel Treatment of Radiation Associated Dysphagia With Statins
Role: lead
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib
Role: lead
Hepatocellular Carcinoma Imaging Using PSMA PET/CT
Role: lead
CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study
Role: lead
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Role: collaborator
Implementing Surgery School Prehabilitation Using Telehealth
Role: collaborator
Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
Role: collaborator
Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease
Role: lead
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Role: collaborator
Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
Role: collaborator
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Role: collaborator
Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
Role: collaborator
ProsTIC Registry of Men Treated With PSMA Theranostics
Role: lead
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
Role: collaborator
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Role: collaborator
Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
Role: lead